Investor Relations

Company Description

News

Financial Reports

Financial Calendar

Presentations

The Share

New Issues

Corporate Governance

IR Contact

Dignitana AB publishes Annual Report for 2021

Dignitana AB's (publ) Annual Report for the financial year 2021 is available on the company's website www.dignitana.com or can be downloaded here. The annual report is published only in Swedish. You can also order a printed version via investorrelations@dignitana.com

For More Information Contact

Investor Relations +1 469 518 5031 investorrelations@dignitana.com

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.com or www.dignicap.com. 

en English
ar Arabicbn Bengalica Catalanzh-CN Chinese (Simplified)cs Czechda Danishnl Dutchen Englishfi Finnishfr Frenchde Germanel Greekgu Gujaratiiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianit Italianja Japanesekn Kannadako Koreanlv Latvianlt Lithuanianml Malayalammr Marathifa Persianpl Polishpt Portuguesepa Punjabiru Russiansk Slovaksl Slovenianes Spanishsv Swedishta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduvi Vietnamese